EMBL scientists discover that an FDA-approved, over-the-counter cough syrup ingredient has potential to treat fibrotic lung ...

The 'Father of the Bride' actress lost her ability to speak for two years before undergoing a laryngoplasty to fix her vocal ...

Excessive drinking can damage the liver. Yet, unlike obesity or high cholesterol, clinicians only screen for alcohol use by ...

The positive opinion could lead to the first approval of a therapy for these conditions in children ... Ofev works by ...

A Phase 2b clinical trial testing Haduvio for IPF cough reached 75% of targeted enrollment but is still recruiting patients ...

Duvakitug positive phase 2b results demonstrate best-in-class potential in ulcerative colitis and Crohn’s diseasePrimary endpoints met in ...

This is done with scar tissue release therapy. With this physical therapy, the scar tissue is massaged and manipulated to become softer, which reduces tightness. It also breaks up any adhesions, where ...

Sanofi and Teva Pharmaceuticals, a US affiliate of Teva Pharmaceutical Industries Ltd., today announced that the RELIEVE UCCD phase 2b study met its primary endpoints in patients with ulcerative ...

Duvakitug positive phase 2b results demonstrate best-in-class potential in ulcerative colitis and Crohn's disease Primary endpoints met in ulcerative colitis (UC) and Crohn's disease (CD), the most ...

It uses electromagnetic waves to target tumors and is available to patients for whom first- and second-line treatments have ...